|
US7576085B2
(en)
*
|
2002-09-23 |
2009-08-18 |
Schering Corporation |
Imidazopyrazines as cyclin dependent kinase inhibitors
|
|
JPWO2005063222A1
(ja)
|
2003-12-26 |
2007-07-19 |
協和醗酵工業株式会社 |
Ｈｓｐ９０ファミリー蛋白質阻害剤
|
|
EP2343304B1
(en)
|
2005-02-16 |
2015-06-10 |
Anacor Pharmaceuticals, Inc. |
Biocidal boronophthalide compounds
|
|
MX2007010073A
(es)
*
|
2005-02-18 |
2007-10-10 |
Astrazeneca Ab |
Metodo para determinar la respuesta de los inhibidores de chk1.
|
|
US20070117804A1
(en)
*
|
2005-11-10 |
2007-05-24 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
|
MX335993B
(es)
*
|
2005-12-30 |
2016-01-07 |
Anacor Pharmaceuticals Inc |
Moleculas pequeñas que contienen boro.
|
|
KR20080110984A
(ko)
|
2005-12-30 |
2008-12-22 |
아나코르 파마슈티칼스 인코포레이티드 |
보론함유 소분자
|
|
EP1978966A4
(en)
*
|
2006-01-23 |
2010-11-10 |
Amira Pharmaceuticals Inc |
TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE
|
|
TW200806670A
(en)
|
2006-04-25 |
2008-02-01 |
Merck & Co Inc |
Inhibitors of checkpoint kinases
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
US8236950B2
(en)
|
2006-12-20 |
2012-08-07 |
Abbott Laboratories |
Anti-viral compounds
|
|
US8012965B2
(en)
|
2006-12-29 |
2011-09-06 |
Rigel Pharmaceuticals, Inc. |
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
|
WO2009002955A1
(en)
*
|
2007-06-27 |
2008-12-31 |
Sanofi-Aventis U.S. Llc |
Process for the preparation of (2r)-2-[4-(7-bromo-2-quinolyloxy)phenoxy]propanoic acid
|
|
CA2721060A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
CL2009001152A1
(es)
|
2008-05-13 |
2009-10-16 |
Array Biopharma Inc |
Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
|
|
WO2010004319A1
(en)
*
|
2008-07-07 |
2010-01-14 |
Astrazeneca Ab |
Combination comprising 6-flu0r0-n- ((1s, 4s) - 4- (6-fluoro-2, 4-di0x0-1- (4'- (piperazin-1- ylmethyl) biphenyl- 3-yl) -1, 2-dihydropyrido [2, 3-d] pyrimidin-3 (4h) - yl) cyclohexyl) imidazo [1,2-a] pyridine -2- carboxamide or a salt
|
|
PL2387395T3
(pl)
|
2009-01-16 |
2015-03-31 |
Rigel Pharmaceuticals Inc |
Inhibitory Axl do zastosowania w terapii skojarzonej do zapobiegania, leczenia lub postępowania z nowotworem przerzutowym
|
|
US8614221B2
(en)
|
2009-03-11 |
2013-12-24 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
|
WO2010118159A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
WO2010118155A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
RU2015143910A
(ru)
|
2010-02-03 |
2018-12-28 |
Инфинити Фармасьютикалз, Инк. |
Ингибиторы амид-гидролазы жирных кислот
|
|
WO2014060381A1
(de)
|
2012-10-18 |
2014-04-24 |
Bayer Cropscience Ag |
Heterocyclische verbindungen als schädlingsbekämpfungsmittel
|
|
JP2016503395A
(ja)
|
2012-10-31 |
2016-02-04 |
バイエル・クロップサイエンス・アクチェンゲゼルシャフト |
病害生物防除剤としての複素環化合物
|
|
KR102164612B1
(ko)
*
|
2014-04-24 |
2020-10-12 |
동아에스티 주식회사 |
아졸계 화합물 및 이를 포함하는 선택적 안드로겐 수용체 효능제
|
|
EP3461480A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
|
|
EP4486741A4
(en)
|
2022-03-01 |
2026-04-08 |
Insilico Medicine Ip Ltd |
Diacylglycerol Kinase (DGK) Alpha Inhibitors and Their Uses
|
|
WO2023165528A1
(en)
*
|
2022-03-01 |
2023-09-07 |
Insilico Medicine Ip Limited |
Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof
|
|
US20240199608A1
(en)
*
|
2022-11-15 |
2024-06-20 |
Eli Lilly And Company |
Ahr agonists
|
|
CN119874716B
(zh)
*
|
2025-03-27 |
2025-07-15 |
上海隆盛化工有限公司 |
1-氯-6,8-二氟-7-异丙基苯并呋喃并[2,3-c]吡啶及其合成方法和应用
|